secwatch / observer
8-K filed June 15, 2023, 7:59 PM ET ticker IMRX CIK 0001790340
other confidence high sentiment neutral materiality 0.10

Immuneering re-elects two directors, ratifies auditor at annual meeting

Immuneering Corp

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Immuneering Corp shareholders approved Ratification of the appointment of RSM US LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023. at the 2023-06-14 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-14
Exact text from the filing
Votes Votes FOR Votes AGAINST ABSTAINED Broker Non-Votes 22,595,867 14,843 100 0 Based on the foregoing votes, Peter Feinberg and Laurie B.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Immuneering Corp shareholders approved Election of two Class II directors to serve until the 2026 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified. at the 2023-06-14 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-14
Exact text from the filing
Peter Feinberg 18,604,285 0 659,292 3,347,233 Laurie B. Keating 18,640,672 0 622,905 3,347,233
View on SEC.gov

48 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Immuneering Corp filing history →

Source: SEC EDGAR
accession 0001790340-23-000029
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.